Sign in
HUGE Stock Price, Chart, Stats & News
FSD Pharma Inc.
Save
66,671
Market cap
–
Current P/E
–
Forward P/E
HUGE chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -106.24% |
ROE | -84.94% |
D/E | 0.03x |
Interest coverage ratio | -65451.89x |
HUGE valuation
P/E | – |
P/S | – |
P/B | 0.27x |
P/CF | -0.32x |
P/FCF | -0.01x |
P/OCF | -0.32x |
PEG | -0.00x |
EV multiple | -0.16x |
About
FSD Pharma Inc. is a biopharmaceutical research and development company, operating through its various subsidiaries. The firm's leading drug candidate, FSD-201, is currently undergoing Phase II clinical trials for the treatment of COVID-19 disease. Additionally, FSD Pharma is actively developing Lucid-PSYCH, a psychoactive molecule identified for its potential in addressing neuropsychiatric conditions such as depressive disorder.
Similar securities
Based on sector and market capitalization
Report issue